Compare CHYM & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHYM | ALGN |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.5B |
| IPO Year | 2025 | 2000 |
| Metric | CHYM | ALGN |
|---|---|---|
| Price | $28.39 | $151.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 16 |
| Target Price | $39.55 | ★ $188.86 |
| AVG Volume (30 Days) | ★ 3.5M | 867.9K |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | 0.20 | ★ 3.09 |
| Revenue | ★ $2,186,770,000.00 | $387,126,000.00 |
| Revenue This Year | $26.70 | $2.80 |
| Revenue Next Year | $21.30 | $3.47 |
| P/E Ratio | $142.03 | ★ $49.15 |
| Revenue Growth | ★ 30.69 | 23.95 |
| 52 Week Low | $15.88 | $130.23 |
| 52 Week High | $35.55 | $200.44 |
| Indicator | CHYM | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.36 | 55.17 |
| Support Level | $25.35 | $138.05 |
| Resistance Level | $31.07 | $154.10 |
| Average True Range (ATR) | 1.11 | 3.85 |
| MACD | -0.02 | 1.49 |
| Stochastic Oscillator | 16.51 | 78.17 |
Chime Financial Inc is a financial technology company that provides digital banking services through its proprietary technology platform in partnership with third-party banks. The company offers various financial products and services designed to meet members' financial needs, including spending accounts, liquidity solutions, credit-building tools, savings products, and community-focused financial services.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.